NCT06685822Completed
Expanding Autism Diagnostic Biomarkers to Kenya
Source: ClinicalTrials.gov · Last updated 5 Aug 2026
Brief summary (registry, in English)
The study will use a non-invasive remote eye-tracking system (Eyelink Portable Duo) to acquire a short series of eye-tracking measures.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 27 (actual)
- First submitted
- 11 Nov 2024
- Start date
- 7 Nov 2024
- Primary completion date
- 1 Jun 2025
- Lead sponsor
- Indiana University
- Diseases
- Autism
- NCT number
- NCT06685822
What you commit to
- Study type: Interventional
- Participants enrolled: 27
- From 7 Nov 2024 to the primary completion date, 1 Jun 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Children younger than 14 months or older than 72 months
Other
- Children not enrolled in the HEAL-R Autism at MTRH study
- Caregivers of children do not speak Kiswahili (local language) or English.
Who the study is looking for
- Children enrolled in the HEAL-R Autism at MTRH study
- Children ages 14-72 months
- Caregivers of children must speak Kiswahili (local language) or English.
Age in the registry: 14 months to 72 months · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Moi Teaching and Referral Hospital Coordinator of this site? Confirm its status | Eldoret | Kenya | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.